E-LIB Suche - Ergebnisse für: Carrato Mena, A.

1

479P Survival outcomes of resected gastroesophageal cancer ..:

Chamorro-Perez, J. ; González Martín, G. ; Corral de la Fuente, E....
Annals of Oncology. 35 (2024) - p. S191 , 2024

Link: https://doi.org/10.1016/..

2

Impact on survival outcomes of poorly controlled hypertensi..:

Pozas, J. ; San Roman Gil, M. ; Orejana Martin, I....
European Urology Open Science. 33 (2021) - p. S301 , 2021

Link: https://doi.org/10.1016/..

3

Management of metastatic prostate cancer in older patients:

Mata Alcaraz, M. ; Artiles Medina, A. ; Pozas Pérez, J....
European Urology Open Science. 33 (2021) - p. S299-S300 , 2021

Link: https://doi.org/10.1016/..

4

Active study: undetected prevalence and clinical inertia in..:

Camps Herrero, C. ; Reina Zoilo, J. J. ; Monge Martín, D....
Clinical and Translational Oncology. 21 (2018) 3 - p. 380-390 , 2018

Link: https://doi.org/10.1007/..

5

Survival impact of the management of medical and urological..:

Serrano Domingo, J.J. ; Lorca Alvaro, J. ; Avarez Rodriguez, S....
European Urology Supplements. 17 (2018) 14 - p. e2875-e2876 , 2018

Link: https://doi.org/10.1016/..

6

Incidence of urological complications in patients with meta..:

Lorca Alvaro, J. ; Serrano Domingo, J.J. ; Álvarez Rodriguez, S....
European Urology Supplements. 17 (2018) 14 - p. e2867-e2869 , 2018

Link: https://doi.org/10.1016/..

7

Oncologist's knowledge and implementation of guidelines for..:

López López, R. ; Camps Herrero, C. ; Khosravi-Shahi, P....
Clinical and Translational Oncology. 20 (2017) 5 - p. 613-618 , 2017

Link: https://doi.org/10.1007/..

8

Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and..:

Garcia Lopez, J.L. ; Rodriguez, Barrios J.M. ; Puig-Junoy, J..
Value in Health. 17 (2014) 7 - p. A638 , 2014

Link: https://doi.org/10.1016/..

9

Documento de Consenso sobre el uso de factores estimuladore..:

Aranda Aguilar, E. ; Camps Herrero, C. ; Carrato Mena, A....
Farmacia Hospitalaria. 34 (2010) - p. 45-50 , 2010

Link: https://doi.org/10.1016/..

10

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrin..:

Vida Navas, Elena María ; Martínez Lorca, Alberto ; Sancho Gutiérrez, Aintzane...
Frontiers in Endocrinology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

11

Spanish Society of Medical Oncology consensus for the use o..:

on behalf of the Spanish Society of Medical Oncology (SEOM) ; Carrato Mena, Alfredo ; Paz-Ares Rodríguez, Luis...
Clinical and Translational Oncology. 11 (2009) 7 - p. 446-454 , 2009

Link: https://doi.org/10.1007/..

12

Spanish Society of Medical Oncology consensus on the use of..:

on behalf of the Spanish Society of Medical Oncology (SEOM) ; Alberola Candel, Vicente ; Carrato Mena, Alfredo...
Clinical and Translational Oncology. 11 (2009) 11 - p. 727-736 , 2009

Link: https://doi.org/10.1007/..

13

Active study: undetected prevalence and clinical inertia in..:

Camps Herrero, C ; Reina Zoilo, J J ; Monge Martín, D...
http://hdl.handle.net/10668/12819. , 2018

Link: http://hdl.handle.net/10..

14

Active study: undetected prevalence and clinical inertia in..:

Camps Herrero, C ; Reina Zoilo, J. J ; Monge Martín, Diana...
https://link.springer.com/article/10.1007/s12094-018-1925-1. , 2018

Link: http://hdl.handle.net/10..

15

Pazopanib in pretreated advanced neuroendocrine tumors: a p..:

Grande-Pulido, E ; Capdevila, J ; Castellano, D...
https://www.annalsofoncology.org/article/S0923-7534(19)31759-4/fulltext. , 2015

Link: https://hdl.handle.net/1..